OTLK EPS Estimates
Outlook Therapeutics, Inc.
$0.50
+$0.03(+5.89%)
23
Overall
40
Value
10
Tech
21
Quality
Market Cap
$114.47M
Volume
2.11M
52W Range
$0.16 - $2.54
Target Price
$5.03
OTLK EPS estimates: the consensus estimate for Outlook Therapeutics, Inc.'s current fiscal year is -$0.45 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
OTLK EPS Estimates
- EPS estimate, current quarter
- $-0.06
- EPS estimate, next quarter
- $-0.05
- EPS estimate, current year
- $-0.45
- EPS estimate, next year
- $-0.12
- EPS growth, 3-year
- +33.91%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.79 |
| 2024 | $-4.06 |
| 2023 | $-4.80 |
| 2022 | $-6.20 |
| 2021 | $-7.00 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OTLK | $0.50 | +5.9% | 2.11M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Outlook Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW